Markets by TradingView
CFN Media TV

The Latest

Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis

Toronto, Ontario–(Newsfile Corp. – September 24, 2024) – Cardiol Therapeutics Inc. (NASDAQ:…

Lithium South Development Announces Completion of Phase I Environmental Baseline Study and Progress on Phases II and III

VANCOUVER, BC, Sept. 12, 2024 /CNW/ — Lithium South Development Corporation (the “Company” or “Lithium South”)…

Stallion Uranium Outlines 9 High Priority Targets in Prolific Southwestern Athabasca Basin

Vancouver, British Columbia, September 11, 2024 – Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB:…

Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024

Full clinical data will be reported in an oral presentation at the…

Aduro Clean Technologies files new patent application to transform waste plastics and renewable oils into high value BTX chemicals

LONDON, Ontario, Sept. 04, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or…

Stallion Uranium Advances Southwestern Athabasca Basin Uranium Project with Gravity Survey

VANCOUVER, British Columbia, Aug. 21, 2024 (GLOBE NEWSWIRE) — Stallion Uranium Corp.…

LITHIUM SOUTH: TEST WORK/ DEVELOPMENT WORK /BUSINESS DEVELOPMENTS UPDATE

VANCOUVER, BC, Aug. 8, 2024 /CNW/ — Lithium South Development Corporation (the “Company” or “Lithium South”)…

Stallion Uranium Confirms Uranium Presence in Graphitic Structure from Final Assay Results

VANCOUVER, British Columbia, Aug. 07, 2024 (GLOBE NEWSWIRE) — Stallion Uranium Corp.…